Effects of Omega-3 Fatty Acid Supplementation on Diabetic Nephropathy Progression in Patients with Diabetes and Hypertriglyceridemia
Autor: | Yujung Yun, Yong Ho Lee, Byung Wan Lee, Bong Soo Cha, Eugene Han, Eun Seok Kang, Beom Seok Kim, Gyuri Kim, Hye Jin Wang |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2016 |
Předmět: |
Male
Physiology lcsh:Medicine Blood Pressure 030204 cardiovascular system & hematology Urine urologic and male genital diseases Gastroenterology Biochemistry Vascular Medicine Diabetic nephropathy chemistry.chemical_compound 0302 clinical medicine Endocrinology Chronic Kidney Disease Medicine and Health Sciences Medicine Diabetic Nephropathies lcsh:Science Hypertriglyceridemia Multidisciplinary Drugs Middle Aged Lipids Body Fluids Cholesterol Nephrology Disease Progression Female medicine.symptom Anatomy Research Article Glomerular Filtration Rate medicine.medical_specialty Endocrine Disorders Renal function 030209 endocrinology & metabolism 03 medical and health sciences Internal medicine Diabetes mellitus Fatty Acids Omega-3 Diabetes Mellitus Albuminuria Humans Aged Retrospective Studies Pharmacology Creatinine Renal Physiology Triglyceride business.industry lcsh:R Statins Biology and Life Sciences Renal System medicine.disease Logistic Models chemistry Metabolic Disorders lcsh:Q business Kidney disease |
Zdroj: | PLoS ONE, Vol 11, Iss 5, p e0154683 (2016) PLoS ONE |
ISSN: | 1932-6203 |
Popis: | Beneficial effects of omega-3 fatty acid (O3FA) supplementation in a wide range of disease condition have been well studied. However, there is limited information regarding the effects of O3FAs on chronic kidney disease (CKD), especially in diabetic nephropathy (DN) with hypertriglyceridemia. We investigate whether O3FA supplementation could help maintain renal function in patients with diabetes and hypertriglyceridemia. Total 344 type 2 diabetic patients with a history of O3FA supplementation for managing hypertriglyceridemia were included. Reduction in urine albumin to creatinine ratio (ACR) and glomerular filtrate rate (GFR) were examined. Subgroup analyses were stratified according to the daily O3FA doses. Serum total cholesterol, triglyceride, and urine ACR significantly reduced after O3FA supplementation. Overall, 172 (50.0%) patients did not experience renal function loss, and 125 (36.3%) patients had a GFR with a positive slope. The patients treated with O3FAs at 4g/day showed greater maintenance in renal function than those treated with lower dosages (p < 0.001). This dose dependent effect remains significant after adjustment for multiple variables. O3FA supplementation in diabetic patients with hypertriglyceridemia shows benefits of reducing albuminuria and maintaining renal function. The effects are dependent on the dose of daily O3FA supplementation. |
Databáze: | OpenAIRE |
Externí odkaz: |